These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8288039)
21. The pharmacology of aldose reductase inhibitors. Kador PF; Robison WG; Kinoshita JH Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907 [No Abstract] [Full Text] [Related]
22. Aldose reductase in the etiology of diabetic complications. 3. Neuropathy. Stribling D; Armstrong FM; Perkins CM; Smith JC J Diabet Complications; 1989; 3(3):139-48. PubMed ID: 2528557 [TBL] [Abstract][Full Text] [Related]
23. Aldose reductase and its inhibition in the control of diabetic complications. Narayanan S Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142 [TBL] [Abstract][Full Text] [Related]
28. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390 [TBL] [Abstract][Full Text] [Related]
29. Aldose reductase inhibitors and cataract. Crabbe MJ Int Ophthalmol; 1991 Jan; 15(1):25-36. PubMed ID: 1901300 [TBL] [Abstract][Full Text] [Related]
30. [Sorbitol route of glucose metabolism and complication of diabetes mellitus]. Efimov AS; Skrobonskaia NA; Petakh NN Probl Endokrinol (Mosk); 1980; 26(3):86-90. PubMed ID: 6773043 [No Abstract] [Full Text] [Related]
31. Discoveries in research on diabetic keratopathy. Cisarik-Fredenburg P Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257 [TBL] [Abstract][Full Text] [Related]
32. [The biochemical basis of the complications of diabetes]. Gabbay KH Journ Annu Diabetol Hotel Dieu; 1984; ():307-20. PubMed ID: 6443221 [No Abstract] [Full Text] [Related]
33. Etiology of cataracts in diabetics. Varma SD; Richards RD Int Ophthalmol Clin; 1984; 24(4):93-110. PubMed ID: 6438012 [No Abstract] [Full Text] [Related]
34. Aldose reductase and sorbitol dehydrogenase distribution in substructures of normal and diabetic rat lens. Collins JG; Corder CN Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):242-3. PubMed ID: 403152 [TBL] [Abstract][Full Text] [Related]
35. The role of aldose reductase inhibitors in diabetic complications: recent trends. Kaul CL; Ramarao P Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322 [TBL] [Abstract][Full Text] [Related]
36. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Tomlinson DR; Moriarty RJ; Mayer JH Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576 [TBL] [Abstract][Full Text] [Related]
37. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors. Jacobson M; Sharma YR; Cotlier E; Hollander JD Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Cameron NE; Cotter MA; Basso M; Hohman TC Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964 [TBL] [Abstract][Full Text] [Related]